These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15935068)

  • 1. DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein.
    Meulener MC; Graves CL; Sampathu DM; Armstrong-Gold CE; Bonini NM; Giasson BI
    J Neurochem; 2005 Jun; 93(6):1524-32. PubMed ID: 15935068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia.
    Rizzu P; Hinkle DA; Zhukareva V; Bonifati V; Severijnen LA; Martinez D; Ravid R; Kamphorst W; Eberwine JH; Lee VM; Trojanowski JQ; Heutink P
    Ann Neurol; 2004 Jan; 55(1):113-8. PubMed ID: 14705119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.
    Xu J; Zhong N; Wang H; Elias JE; Kim CY; Woldman I; Pifl C; Gygi SP; Geula C; Yankner BA
    Hum Mol Genet; 2005 May; 14(9):1231-41. PubMed ID: 15790595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.
    Chen L; Feany MB
    Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
    Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
    J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.
    Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF
    Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of genetic contributions to Parkinson's disease.
    Hofer A; Gasser T
    J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
    Engelender S; Kaminsky Z; Guo X; Sharp AH; Amaravi RK; Kleiderlein JJ; Margolis RL; Troncoso JC; Lanahan AA; Worley PF; Dawson VL; Dawson TM; Ross CA
    Nat Genet; 1999 May; 22(1):110-4. PubMed ID: 10319874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes.
    Macedo MG; Anar B; Bronner IF; Cannella M; Squitieri F; Bonifati V; Hoogeveen A; Heutink P; Rizzu P
    Hum Mol Genet; 2003 Nov; 12(21):2807-16. PubMed ID: 12952867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biochemistry of Parkinson's disease.
    Cookson MR
    Annu Rev Biochem; 2005; 74():29-52. PubMed ID: 15952880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.
    Shendelman S; Jonason A; Martinat C; Leete T; Abeliovich A
    PLoS Biol; 2004 Nov; 2(11):e362. PubMed ID: 15502874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
    Lee VM; Giasson BI; Trojanowski JQ
    Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
    Norris EH; Giasson BI
    Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain.
    Baulac S; LaVoie MJ; Strahle J; Schlossmacher MG; Xia W
    Mol Cell Neurosci; 2004 Nov; 27(3):236-46. PubMed ID: 15519239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the epitope of a monoclonal antibody to DJ-1.
    Miller DW; Wilson CR; Kaleem MA; Blackinton J; Cookson MR
    Neurosci Lett; 2005 Feb; 374(3):203-6. PubMed ID: 15663963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective enrichment of DJ-1 protein in primate striatal neuronal processes: implications for Parkinson's disease.
    Olzmann JA; Bordelon JR; Muly EC; Rees HD; Levey AI; Li L; Chin LS
    J Comp Neurol; 2007 Jan; 500(3):585-99. PubMed ID: 17120294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.